2+ day, 17+ hour ago   (75+ words) 11 September 2026 | Friday | News Anchored by the Life Index system and built on precise risk stratification and systematic health assessments, this model connects upstream to BGI Genomics' full portfolio of multi-omics tests and interventions while empowering downstream healthcare providers and health…...

1+ week, 4+ day ago   (60+ words) 02 September 2026 | Wednesday | News The proceeds will be used to further advance Convergen's proprietary degrader platform and accelerate its pipeline for neurodegenerative disorders and other protein aggregation diseases. Two Chairs, 11,000 Kilometres Apart: The Human Cost of Asia’s Plasma Dependence China Plus…...

1+ week, 5+ day ago   (180+ words) 01 September 2026 | Tuesday | News Data4Life and Monash Health have partnered to optimize clinical trial design and execution, complemented by educational workshops and professional training programs, with a shared commitment to improving patient outcomes. The Global Relations Office is a new site launched…...

1+ week, 5+ day ago   (161+ words) 01 September 2026 | Tuesday | News SIBIONICS showcased its sensor innovation and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbourne from 18–21 August. Through Booth #1, a scientific symposium and on-site interviews with Credentialled Diabetes Educators (CDEs), the…...

1+ week, 6+ day ago   (177+ words) 31 August 2026 | Monday | News Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Sanyou Bio"), announced the official launch of Clicklinks, an AI-STAL and SAI-DA powered collaborative network designed to support original drug discovery and preclinical development. Clicklinks: An Open and Collaborative…...

2+ week, 4+ day ago   (215+ words) 26 August 2026 | Wednesday | News Ir Dr Ted Suen, Chief Executive Officer of ASTRI (left) and Professor Stephen Cheung Yan-leung, President of Saint Francis University (right), sign a Memorandum of Understanding today (24 August) establishing a strategic partnership to advance research and development…...

2+ week, 6+ day ago   (159+ words) 24 August 2026 | Monday | News Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Through its entry into Lilly Gateway Labs, Rznomics plans to…...

2+ week, 6+ day ago   (133+ words) 24 August 2026 | Monday | News During its first year, the ai² Futures Lab™ engaged 64 students and identified more than 45 potential acquisition assets. Several of these advanced into active pipeline discussions, demonstrating how the program expands Lōkahi’s sourcing reach and analytical capacity while supporting…...

3+ week, 2+ day ago   (142+ words) 21 August 2026 | Friday | News 68Ga-NYM096 is the first China-originated innovative radiopharmaceutical to receive FDA Breakthrough Therapy Designation. It is being developed as a non-invasive PET imaging agent to enable the characterization of indeterminate renal masses identified by Computed Tomography (CT) or Magnetic…...

3+ week, 2+ day ago   (98+ words) 21 August 2026 | Friday | News Leveraging IPO proceeds, Ingenia is expediting clinical development across its broader pipeline: "Going public on KOSDAQ is a transformative milestone for Ingenia as we lead a paradigm shift in vascular disease treatments," said Sangyeul Han, PhD, CEO…...